BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33169732)

  • 1. Deformable liposomal codelivery of vorinostat and simvastatin promotes antitumor responses through remodeling tumor microenvironment.
    Tu B; He Y; Chen B; Wang Y; Gao Y; Shi M; Liu T; Asrorov AM; Huang Y
    Biomater Sci; 2020 Dec; 8(24):7166-7176. PubMed ID: 33169732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression.
    Rauca VF; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Mot AC; Rakosy-Tican E; Sesarman A; Banciu M
    Sci Rep; 2021 Nov; 11(1):22102. PubMed ID: 34764332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery.
    Jin H; He Y; Zhao P; Hu Y; Tao J; Chen J; Huang Y
    Theranostics; 2019; 9(1):265-278. PubMed ID: 30662566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery.
    Chen B; Gao A; Tu B; Wang Y; Yu X; Wang Y; Xiu Y; Wang B; Wan Y; Huang Y
    Biomaterials; 2020 Oct; 255():120187. PubMed ID: 32590192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery.
    Zheng Z; Zhang J; Jiang J; He Y; Zhang W; Mo X; Kang X; Xu Q; Wang B; Huang Y
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
    Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
    BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems pharmacology dissection of
    Huang C; Li Z; Zhu J; Chen X; Hao Y; Yang R; Huang R; Zhou J; Wang Z; Xiao W; Zheng C; Wang Y
    Aging (Albany NY); 2021 Jan; 13(2):2912-2940. PubMed ID: 33460401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling Tumor-Associated Macrophages and Neovascularization Overcomes EGFR
    Yin W; Yu X; Kang X; Zhao Y; Zhao P; Jin H; Fu X; Wan Y; Peng C; Huang Y
    Small; 2018 Nov; 14(47):e1802372. PubMed ID: 30307695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic and therapeutic study of novel anti-tumor function of natural compound imperialine for treating non-small cell lung cancer.
    Lin Q; Qu M; Patra HK; He S; Wang L; Hu X; Xiao L; Fu Y; Gong T; He Q; Zhang L; Sun X; Zhang Z
    J Ethnopharmacol; 2020 Jan; 247():112283. PubMed ID: 31605736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages.
    Li Y; Cao F; Li M; Li P; Yu Y; Xiang L; Xu T; Lei J; Tai YY; Zhu J; Yang B; Jiang Y; Zhang X; Duo L; Chen P; Yu X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):259. PubMed ID: 30373678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling "cold" tumor immune microenvironment
    He Y; Fang Y; Zhang M; Zhao Y; Tu B; Shi M; Muhitdinov B; Asrorov A; Xu Q; Huang Y
    Acta Pharm Sin B; 2022 Apr; 12(4):2057-2073. PubMed ID: 35847495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
    Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
    J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5-fluorouracil in vivo.
    Luput L; Sesarman A; Porfire A; Achim M; Muntean D; Casian T; Patras L; Rauca VF; Drotar DM; Stejerean I; Tomuta I; Vlase L; Dragos N; Toma VA; Licarete E; Banciu M
    Cancer Sci; 2020 Apr; 111(4):1344-1356. PubMed ID: 31960547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment.
    Wang R; Qu J; Tang X; Zhang J; Ou A; Li Q; Chen G; Zheng C; Muhitdinov B; Huang Y
    Mol Pharm; 2023 Aug; 20(8):3925-3936. PubMed ID: 37505210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing neobavaisoflavone nanoemulsion suppresses lung cancer progression by regulating tumor microenvironment.
    Ye H; He X; Feng X
    Biomed Pharmacother; 2020 Sep; 129():110369. PubMed ID: 32563983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
    Shima T; Shimoda M; Shigenobu T; Ohtsuka T; Nishimura T; Emoto K; Hayashi Y; Iwasaki T; Abe T; Asamura H; Kanai Y
    Cancer Sci; 2020 Feb; 111(2):727-738. PubMed ID: 31821665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
    Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
    Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
    Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment.
    Rebelo SP; Pinto C; Martins TR; Harrer N; Estrada MF; Loza-Alvarez P; Cabeçadas J; Alves PM; Gualda EJ; Sommergruber W; Brito C
    Biomaterials; 2018 May; 163():185-197. PubMed ID: 29477032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-targeting biomimetic delivery for anti-glioma activity
    Zhao P; Wang Y; Kang X; Wu A; Yin W; Tang Y; Wang J; Zhang M; Duan Y; Huang Y
    Chem Sci; 2018 Mar; 9(10):2674-2689. PubMed ID: 29732051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.